StockStory.org on MSN4d
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals StocksThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal (NASDAQ ... producing bioequivalent versions of branded drugs once their ...
Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is ...
Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) has approved an amendment to its previously disclosed limited duration ...
Major pharmaceutical corporations are increasingly turning to cell and gene therapies to fill possible revenue shortages as many product patents are about to expire. Despite this enthusiasm ...
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts ... as many product patents are about to expire. Despite this optimism, there has been a reduction ...
As market participants await the onset of the monthly F&O expiry week with the opening bell on March 24, here are a number of ...
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal ... drugs once their patents expire. These companies benefit from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results